Raymond K. Allen

Family Medicine

512 Nelson Blvd # 200
Kingstree, SC 29556

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304).

Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304).

Journal: Future oncology (London, England)

Published: January 17, 2025

Showing 1-1 of 1

Last Updated: 09/26/2026